The Impact of Obesity on Clostridioides difficile Infection Outcomes: A Retrospective Cohort Study
<b>Background:</b> Studies have demonstrated a positive correlation between high body mass index (BMI) and an increased risk of <i>Clostridioides difficile</i> infection (CDI), independent of antibiotic usage or healthcare exposures. <b>Aim:</b> To compare the outcomes of obese (BMI ≥ 30 kg/m<sup>2</sup>) and non-obese (BMI < 30 kg/m<sup>2</sup>) hospitalized patients with CDI. <b>Methods:</b> This retrospective cohort study included patients with CDI hospitalized in Beilinson hospital between January 2013 and January 2020. The primary outcome was 90-day all-cause mortality. Secondary outcomes included 30-day mortality, colectomy, intensive care unit (ICU) admission and length of hospital stay (LOS). Multivariate analysis was performed to identify the risk factors independently associated with 90-day mortality. <b>Results:</b> The study included 889 patients: 131 (15%) obese and 758 (85%) non-obese. The obese group was younger (median age 65 years vs. 73 years (<i>p</i> < 0.01)) and with a higher rate of diabetes mellitus (57/131 (44%) vs. 180/758 (24%) (<i>p</i> < 0.01)). The 90-day mortality was lower in the obese group: 19/131 (15%) vs. 170/752 (23%) (<i>p</i> = 0.04). The 30-day mortality was 8/131 (6%) vs. 96/757 (13%) (<i>p</i> = 0.03). ICU admission was 9/131 (7%) vs. 23/758 (3%) (<i>p</i> = 0.03), and median LOS was 19 vs. 12 days (<i>p</i> < 0.01) in obese and non-obese groups, respectively. In the multivariable analysis, after adjustment for age, Charlson's comorbidity index ≥3, assistance in activities of daily living, treatment with proton pump inhibitors and severity of illness, obesity was not a significant risk factor for 90-day mortality (OR = 0.65, 95% CI: 0.38-1.01; <i>p</i> = 0.1). <b>Conclusions:</b> In this study, obesity was not significantly associated with 90-day mortality after adjustment for other risk factors; however, ICU admission was higher and LOS longer in this group.
Authors
- Alaa Atamna (ORCID: https://orcid.org/0000-0002-1351-7135)
- Haim Ben Zvi
- Avishay Elis (ORCID: https://orcid.org/0000-0001-7924-3088)
- Gida Ayada
- Tanya Babich
- Amir Nutman (ORCID: https://orcid.org/0000-0002-1599-2618)
- Jihad Bishara (ORCID: https://orcid.org/0000-0003-4014-8272)
- Manar Khalaila
- Anan Zriek
Institutions
- Tel Aviv University (IL)
- Rabin Medical Center (IL)
- Wolfson Medical Center (IL)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-08-03
- DOI
- https://doi.org/10.3390/jcm14155459
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00